Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents

Melanogenesis is based on the enzymatic conversion of the amino acid tyrosine, through a series of intermediates, to melanin pigments. The nature of the enzymes involved in the different steps of melanogenesis has been intensely debated. However, it is now believed that tyrosinase is responsible for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatology (Basel) 2002-01, Vol.205 (4), p.329-339
1. Verfasser: Kasraee, Behrooz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 339
container_issue 4
container_start_page 329
container_title Dermatology (Basel)
container_volume 205
creator Kasraee, Behrooz
description Melanogenesis is based on the enzymatic conversion of the amino acid tyrosine, through a series of intermediates, to melanin pigments. The nature of the enzymes involved in the different steps of melanogenesis has been intensely debated. However, it is now believed that tyrosinase is responsible for the conversion of tyrosine to dopa and of dopa to dopaquinone, and that peroxidase accomplishes the oxidative polymerization of the eventually formed indoles to eumelanin pigments. Some very few investigators have also considered a main role for peroxidase in initiating melanogenesis. At present, most different hypotheses are focused on tyrosinase-mediated mechanisms to elucidate the melanocytotoxic and depigmenting activities of chemicals. However, many properties of these agents cannot be explained by such mechanisms. Most of the melanocytotoxic agents (e.g. hydroquinone, catechols, butylated hydroxyanisole) can be converted to cytotoxic species, such as quinones, by the peroxidase-H 2 O 2 system. On the other hand, many of the melanogenesis inhibitors which are not known to inhibit tyrosinase (e.g. glucocorticoids, ascorbic acid, indomethacin) have the capacity to strongly inhibit peroxidase activity. We have proposed that peroxidase-mediated mechanisms, in addition to or in several instances rather than tyrosinase-mediated mechanisms, can explain the melanocytotoxic and depigmenting properties of such agents.
doi_str_mv 10.1159/000066439
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_220154065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734920751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-33ade4230f21227247dca28be7a4ddf4c128c31292e1641af00ba51c0ff05f83</originalsourceid><addsrcrecordid>eNptkM1PAjEUxBujEUUPnk1M483Datvtfh0JopJANIb7prSvUIQutoWIf71VCFx8l75Mf51JB6ErSu4pzaoHEifPeVodoTPKGU2qMmXHcSe0TMo8z1ro3PtZpFhZVKeoRRnnPGX5Gfp-A9d8GSU8JENQRgRQeAhyKqzxC487DnDfrpv5OurG4jCFeD0XtpGb0IT4VGJh1U6bgAVvfNK3UzM2wdgJ7mkNMnjcaNydwsJIMcedyAV_gU60mHu43J1tNHrqjbovyeD1ud_tDBIZvxKSNBUKOEuJZpSxgvFCScHKMRSCK6W5pKyUKWUVA5pzKjQhY5FRSbQmmS7TNrrd2i5d87kCH-pZs3I2JtaMEZpxkmcRuttC0jXeO9D10pmFcJuakvq343rfcWRvdoar8QLUgdyVekj8EG4Cbg88vg__HOql0hG6_hfaZvwAOs-L0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220154065</pqid></control><display><type>article</type><title>Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents</title><source>Karger Journals</source><source>MEDLINE</source><creator>Kasraee, Behrooz</creator><creatorcontrib>Kasraee, Behrooz</creatorcontrib><description>Melanogenesis is based on the enzymatic conversion of the amino acid tyrosine, through a series of intermediates, to melanin pigments. The nature of the enzymes involved in the different steps of melanogenesis has been intensely debated. However, it is now believed that tyrosinase is responsible for the conversion of tyrosine to dopa and of dopa to dopaquinone, and that peroxidase accomplishes the oxidative polymerization of the eventually formed indoles to eumelanin pigments. Some very few investigators have also considered a main role for peroxidase in initiating melanogenesis. At present, most different hypotheses are focused on tyrosinase-mediated mechanisms to elucidate the melanocytotoxic and depigmenting activities of chemicals. However, many properties of these agents cannot be explained by such mechanisms. Most of the melanocytotoxic agents (e.g. hydroquinone, catechols, butylated hydroxyanisole) can be converted to cytotoxic species, such as quinones, by the peroxidase-H 2 O 2 system. On the other hand, many of the melanogenesis inhibitors which are not known to inhibit tyrosinase (e.g. glucocorticoids, ascorbic acid, indomethacin) have the capacity to strongly inhibit peroxidase activity. We have proposed that peroxidase-mediated mechanisms, in addition to or in several instances rather than tyrosinase-mediated mechanisms, can explain the melanocytotoxic and depigmenting properties of such agents.</description><identifier>ISSN: 1018-8665</identifier><identifier>EISSN: 1421-9832</identifier><identifier>DOI: 10.1159/000066439</identifier><identifier>PMID: 12444326</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Animals ; Catechols - pharmacology ; Catechols - toxicity ; Editorial ; Humans ; Hydroquinones - pharmacology ; Hydroquinones - toxicity ; Hyperpigmentation - drug therapy ; Melanins - biosynthesis ; Melanocytes - drug effects ; Melanocytes - enzymology ; Melatonin - antagonists &amp; inhibitors ; Melatonin - biosynthesis ; Methimazole - pharmacology ; Methimazole - toxicity ; Monophenol Monooxygenase - antagonists &amp; inhibitors ; Monophenol Monooxygenase - drug effects ; Monophenol Monooxygenase - metabolism ; Peroxidase - drug effects ; Peroxidase - metabolism ; Sensitivity and Specificity</subject><ispartof>Dermatology (Basel), 2002-01, Vol.205 (4), p.329-339</ispartof><rights>2002 S. Karger AG, Basel</rights><rights>Copyright 2002 S. Karger AG, Basel</rights><rights>Copyright (c) 2002 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-33ade4230f21227247dca28be7a4ddf4c128c31292e1641af00ba51c0ff05f83</citedby><cites>FETCH-LOGICAL-c421t-33ade4230f21227247dca28be7a4ddf4c128c31292e1641af00ba51c0ff05f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2423,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12444326$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kasraee, Behrooz</creatorcontrib><title>Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents</title><title>Dermatology (Basel)</title><addtitle>Dermatology</addtitle><description>Melanogenesis is based on the enzymatic conversion of the amino acid tyrosine, through a series of intermediates, to melanin pigments. The nature of the enzymes involved in the different steps of melanogenesis has been intensely debated. However, it is now believed that tyrosinase is responsible for the conversion of tyrosine to dopa and of dopa to dopaquinone, and that peroxidase accomplishes the oxidative polymerization of the eventually formed indoles to eumelanin pigments. Some very few investigators have also considered a main role for peroxidase in initiating melanogenesis. At present, most different hypotheses are focused on tyrosinase-mediated mechanisms to elucidate the melanocytotoxic and depigmenting activities of chemicals. However, many properties of these agents cannot be explained by such mechanisms. Most of the melanocytotoxic agents (e.g. hydroquinone, catechols, butylated hydroxyanisole) can be converted to cytotoxic species, such as quinones, by the peroxidase-H 2 O 2 system. On the other hand, many of the melanogenesis inhibitors which are not known to inhibit tyrosinase (e.g. glucocorticoids, ascorbic acid, indomethacin) have the capacity to strongly inhibit peroxidase activity. We have proposed that peroxidase-mediated mechanisms, in addition to or in several instances rather than tyrosinase-mediated mechanisms, can explain the melanocytotoxic and depigmenting properties of such agents.</description><subject>Animals</subject><subject>Catechols - pharmacology</subject><subject>Catechols - toxicity</subject><subject>Editorial</subject><subject>Humans</subject><subject>Hydroquinones - pharmacology</subject><subject>Hydroquinones - toxicity</subject><subject>Hyperpigmentation - drug therapy</subject><subject>Melanins - biosynthesis</subject><subject>Melanocytes - drug effects</subject><subject>Melanocytes - enzymology</subject><subject>Melatonin - antagonists &amp; inhibitors</subject><subject>Melatonin - biosynthesis</subject><subject>Methimazole - pharmacology</subject><subject>Methimazole - toxicity</subject><subject>Monophenol Monooxygenase - antagonists &amp; inhibitors</subject><subject>Monophenol Monooxygenase - drug effects</subject><subject>Monophenol Monooxygenase - metabolism</subject><subject>Peroxidase - drug effects</subject><subject>Peroxidase - metabolism</subject><subject>Sensitivity and Specificity</subject><issn>1018-8665</issn><issn>1421-9832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkM1PAjEUxBujEUUPnk1M483Datvtfh0JopJANIb7prSvUIQutoWIf71VCFx8l75Mf51JB6ErSu4pzaoHEifPeVodoTPKGU2qMmXHcSe0TMo8z1ro3PtZpFhZVKeoRRnnPGX5Gfp-A9d8GSU8JENQRgRQeAhyKqzxC487DnDfrpv5OurG4jCFeD0XtpGb0IT4VGJh1U6bgAVvfNK3UzM2wdgJ7mkNMnjcaNydwsJIMcedyAV_gU60mHu43J1tNHrqjbovyeD1ud_tDBIZvxKSNBUKOEuJZpSxgvFCScHKMRSCK6W5pKyUKWUVA5pzKjQhY5FRSbQmmS7TNrrd2i5d87kCH-pZs3I2JtaMEZpxkmcRuttC0jXeO9D10pmFcJuakvq343rfcWRvdoar8QLUgdyVekj8EG4Cbg88vg__HOql0hG6_hfaZvwAOs-L0Q</recordid><startdate>20020101</startdate><enddate>20020101</enddate><creator>Kasraee, Behrooz</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20020101</creationdate><title>Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents</title><author>Kasraee, Behrooz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-33ade4230f21227247dca28be7a4ddf4c128c31292e1641af00ba51c0ff05f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Catechols - pharmacology</topic><topic>Catechols - toxicity</topic><topic>Editorial</topic><topic>Humans</topic><topic>Hydroquinones - pharmacology</topic><topic>Hydroquinones - toxicity</topic><topic>Hyperpigmentation - drug therapy</topic><topic>Melanins - biosynthesis</topic><topic>Melanocytes - drug effects</topic><topic>Melanocytes - enzymology</topic><topic>Melatonin - antagonists &amp; inhibitors</topic><topic>Melatonin - biosynthesis</topic><topic>Methimazole - pharmacology</topic><topic>Methimazole - toxicity</topic><topic>Monophenol Monooxygenase - antagonists &amp; inhibitors</topic><topic>Monophenol Monooxygenase - drug effects</topic><topic>Monophenol Monooxygenase - metabolism</topic><topic>Peroxidase - drug effects</topic><topic>Peroxidase - metabolism</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kasraee, Behrooz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Dermatology (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kasraee, Behrooz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents</atitle><jtitle>Dermatology (Basel)</jtitle><addtitle>Dermatology</addtitle><date>2002-01-01</date><risdate>2002</risdate><volume>205</volume><issue>4</issue><spage>329</spage><epage>339</epage><pages>329-339</pages><issn>1018-8665</issn><eissn>1421-9832</eissn><abstract>Melanogenesis is based on the enzymatic conversion of the amino acid tyrosine, through a series of intermediates, to melanin pigments. The nature of the enzymes involved in the different steps of melanogenesis has been intensely debated. However, it is now believed that tyrosinase is responsible for the conversion of tyrosine to dopa and of dopa to dopaquinone, and that peroxidase accomplishes the oxidative polymerization of the eventually formed indoles to eumelanin pigments. Some very few investigators have also considered a main role for peroxidase in initiating melanogenesis. At present, most different hypotheses are focused on tyrosinase-mediated mechanisms to elucidate the melanocytotoxic and depigmenting activities of chemicals. However, many properties of these agents cannot be explained by such mechanisms. Most of the melanocytotoxic agents (e.g. hydroquinone, catechols, butylated hydroxyanisole) can be converted to cytotoxic species, such as quinones, by the peroxidase-H 2 O 2 system. On the other hand, many of the melanogenesis inhibitors which are not known to inhibit tyrosinase (e.g. glucocorticoids, ascorbic acid, indomethacin) have the capacity to strongly inhibit peroxidase activity. We have proposed that peroxidase-mediated mechanisms, in addition to or in several instances rather than tyrosinase-mediated mechanisms, can explain the melanocytotoxic and depigmenting properties of such agents.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>12444326</pmid><doi>10.1159/000066439</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1018-8665
ispartof Dermatology (Basel), 2002-01, Vol.205 (4), p.329-339
issn 1018-8665
1421-9832
language eng
recordid cdi_proquest_journals_220154065
source Karger Journals; MEDLINE
subjects Animals
Catechols - pharmacology
Catechols - toxicity
Editorial
Humans
Hydroquinones - pharmacology
Hydroquinones - toxicity
Hyperpigmentation - drug therapy
Melanins - biosynthesis
Melanocytes - drug effects
Melanocytes - enzymology
Melatonin - antagonists & inhibitors
Melatonin - biosynthesis
Methimazole - pharmacology
Methimazole - toxicity
Monophenol Monooxygenase - antagonists & inhibitors
Monophenol Monooxygenase - drug effects
Monophenol Monooxygenase - metabolism
Peroxidase - drug effects
Peroxidase - metabolism
Sensitivity and Specificity
title Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T14%3A04%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peroxidase-Mediated%20Mechanisms%20Are%20Involved%20in%20the%20Melanocytotoxic%20and%20Melanogenesis-Inhibiting%20Effects%20of%20Chemical%20Agents&rft.jtitle=Dermatology%20(Basel)&rft.au=Kasraee,%20Behrooz&rft.date=2002-01-01&rft.volume=205&rft.issue=4&rft.spage=329&rft.epage=339&rft.pages=329-339&rft.issn=1018-8665&rft.eissn=1421-9832&rft_id=info:doi/10.1159/000066439&rft_dat=%3Cproquest_pubme%3E734920751%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220154065&rft_id=info:pmid/12444326&rfr_iscdi=true